Dare Bioscience Inc (NAS:DARE)
$ 0.435 0.025 (6.1%) Market Cap: 43.97 Mil Enterprise Value: 40.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 26/100

Q1 2022 Dare Bioscience Inc Earnings Call Transcript

May 12, 2022 / 08:30PM GMT
Release Date Price: $1.03 (+9.56%)
Operator

Welcome to the conference call hosted by Dare Bioscience to review the company's financial results for the quarter ended March 31, 2022, and to provide a general business update. This call is being recorded. My name is Delfin, and I will be your operator. With us today are Ms. Sabrina Martucci Johnson, Dare's President and Chief Executive Officer; Mr. John Fair, Dare's Chief Strategy Officer; and Ms. Lisa Walters-Hoffert, Dare's Chief Financial Officer.

Ms. Johnson, please proceed.

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Thank you. Good afternoon, and welcome to our first quarter 2022 financial results and business update call for Dare Bioscience. Our plan today is to review our first quarter results, discuss developments since our last call in March and use the time to review our business strategy and highlight our objectives and milestones anticipated for 2022.

Before I begin, I'd like to remind you that today's discussion will include forward-looking statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot